BIANCHI, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.833
EU - Europa 4.186
AS - Asia 4.073
SA - Sud America 498
Continente sconosciuto - Info sul continente non disponibili 146
AF - Africa 114
OC - Oceania 25
Totale 18.875
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.555
GB - Regno Unito 1.282
IT - Italia 1.129
SG - Singapore 1.119
CN - Cina 932
HK - Hong Kong 563
VN - Vietnam 446
SE - Svezia 429
BR - Brasile 352
DE - Germania 276
BD - Bangladesh 234
FR - Francia 231
RU - Federazione Russa 200
CA - Canada 146
FI - Finlandia 142
KR - Corea 141
TR - Turchia 134
UA - Ucraina 134
IN - India 95
ID - Indonesia 83
NL - Olanda 56
BG - Bulgaria 48
JP - Giappone 47
AR - Argentina 46
IR - Iran 42
MX - Messico 38
IQ - Iraq 37
PL - Polonia 32
ZA - Sudafrica 32
SI - Slovenia 30
LT - Lituania 27
ES - Italia 25
CO - Colombia 24
PK - Pakistan 24
AU - Australia 23
BE - Belgio 23
EC - Ecuador 22
AE - Emirati Arabi Uniti 20
SA - Arabia Saudita 20
CZ - Repubblica Ceca 18
KE - Kenya 18
QA - Qatar 18
EG - Egitto 16
IE - Irlanda 16
TT - Trinidad e Tobago 15
UZ - Uzbekistan 15
CL - Cile 14
MY - Malesia 13
CH - Svizzera 12
SV - El Salvador 12
CR - Costa Rica 11
MA - Marocco 11
AT - Austria 10
IL - Israele 10
JO - Giordania 10
DZ - Algeria 9
EU - Europa 9
HN - Honduras 9
JM - Giamaica 9
NI - Nicaragua 9
PY - Paraguay 9
TW - Taiwan 9
VE - Venezuela 9
BO - Bolivia 8
GR - Grecia 8
GT - Guatemala 8
PH - Filippine 8
LU - Lussemburgo 7
PR - Porto Rico 7
PT - Portogallo 7
DK - Danimarca 6
PE - Perù 6
TH - Thailandia 6
TN - Tunisia 6
AL - Albania 5
AZ - Azerbaigian 5
EE - Estonia 5
MN - Mongolia 5
NP - Nepal 5
OM - Oman 5
RO - Romania 5
SC - Seychelles 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
LB - Libano 4
NO - Norvegia 4
PS - Palestinian Territory 4
SN - Senegal 4
BB - Barbados 3
CW - ???statistics.table.value.countryCode.CW??? 3
GP - Guadalupe 3
HR - Croazia 3
RS - Serbia 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BH - Bahrain 2
BS - Bahamas 2
BW - Botswana 2
BY - Bielorussia 2
Totale 18.704
Salva come PNG Salva come JPEG
Città #
Ashburn 1.166
Southend 949
Fairfield 818
Santa Clara 698
Singapore 689
San Jose 577
Hong Kong 542
Chandler 464
Woodbridge 428
Houston 407
Council Bluffs 338
Seattle 310
Cambridge 281
Wilmington 259
Ann Arbor 250
Nyköping 215
Beijing 212
Modena 211
Dearborn 199
Jacksonville 191
Hefei 187
Los Angeles 170
London 167
New York 145
Chicago 134
Ho Chi Minh City 133
Seoul 120
Hanoi 102
The Dalles 99
San Diego 80
Milan 79
Helsinki 78
Izmir 71
Jakarta 63
Dallas 56
Buffalo 54
Salt Lake City 54
Shanghai 52
Bologna 50
Princeton 50
Lauterbourg 49
Munich 49
Fremont 48
Sofia 47
Rome 45
Eugene 44
São Paulo 42
Columbus 40
Toronto 40
Reggio Emilia 39
Montreal 38
Shenzhen 38
Moscow 36
Sant'Ilario d'Enza 36
Phoenix 34
Tokyo 34
Tampa 33
Elk Grove Village 29
Frankfurt am Main 29
Orem 29
Turku 26
Dong Ket 25
Naples 25
Des Moines 23
Boardman 22
Bremen 22
Brooklyn 22
Hillsboro 22
Parma 21
Da Nang 20
Redwood City 20
Brussels 19
San Francisco 19
Warsaw 19
Denver 18
Haiphong 18
Atlanta 17
Doha 17
Florence 17
Nairobi 17
Nuremberg 17
Chennai 16
Johannesburg 16
Poplar 16
Dublin 15
Falls Church 15
Las Vegas 15
Manchester 15
North Bergen 15
Turin 15
Amsterdam 14
Guangzhou 13
Miami 13
Tashkent 13
Belo Horizonte 12
Detroit 12
Sterling 12
Biên Hòa 11
Boston 11
Brasília 11
Totale 12.613
Salva come PNG Salva come JPEG
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 589
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 532
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 527
miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1 485
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 480
C-Myb Restrains Megakaryopoiesis through the Hsa-MiR-486-3p-Driven Down-Regulation of C-Maf 476
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 432
Genomic landscape of megakaryopoiesis and platelet function defects 426
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 420
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice 419
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 418
Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage 412
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 410
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 408
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 392
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) 389
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 389
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 366
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 364
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 364
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 359
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 359
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 352
Regulatory Mrna/Microrna Networks in CD34+ Cells From Primary Myelofibrosis 347
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 340
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 336
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 336
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 315
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 315
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 312
HGM 2010 Programme / Abstract 310
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib 297
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 297
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 295
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 290
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 288
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 288
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 287
Abnormal expression of WT1-as, MEG3 and ANRIL long non-coding RNAs in primary myelofibrosis and their clinical correlates 282
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 280
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 277
Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 277
Regulatory mRNA/microRNA networks in CD34+ cells from Primary Myelofibrosis 275
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 273
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 268
Regulatory mRNA/microRNA networks in CD34+ cells from Primary Myelofibrosis 267
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 265
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 249
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells. the crucial role of PTEN. 243
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis 232
Comparison between Cultivated Oral Mucosa and Ocular Surface Epithelia for COMET Patients Follow-Up 231
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 226
MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF 206
Silencing CD34 antigen in human hematopoietic stem cells 201
Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts 192
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis 155
Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model 55
Totale 18.875
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.163
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022822 0 0 0 0 58 77 51 78 119 95 189 155
2022/20231.520 172 192 135 131 190 167 29 135 159 34 74 102
2023/20241.078 49 47 83 112 146 77 200 126 10 31 60 137
2024/20252.899 83 28 50 164 574 451 262 210 264 123 354 336
2025/20265.628 374 182 352 614 984 353 702 230 551 579 363 344
2026/20271.461 163 330 365 494 109 0 0 0 0 0 0 0
Totale 18.875